Case study: Prescribing a potent program of deferred compensation for a pharmaceutical company’s executives By Dominick Pizzano | 08 June 2015 The challenge A U.S. start-up subsidiary of a foreign pharmaceutical corporation was seeking to provide salary and bonus deferral opportunities for its executives and grant one of the executives with additional deferred compensation that would recognize both his past service and particularly important role in the organization. While the corporation already maintained a qualified 401(k) plan for its employees, it did not maintain any nonqualified plan arrangements for executives. Challenges presented by this case included the following: The decision-makers at the corporation (many of whom were scientists) were not familiar with the intricacies of non

Join for free to read